Robust B-cell depletion observed with budoprutug subcutaneous formulation in healthy volunteers, supporting continued ...
UCB has agreed to acquire Candid Therapeutics for up-to-$2.2 billion, in a deal designed to expand the buyer’s presence in ...
Climb Bio (NASDAQ:CLYM) used an investor R&D spotlight event to outline its strategy around CD19-targeted B-cell depletion ...
This acquisition marks UCB’s second foray into the TCE space – closely following a blockbuster licensing deal with TCE ...
UCB to buy clinical-stage biotech company, Candid Therapeuticsfor US$ 2.2 billion: Brussels, Belgium Tuesday, May 5, 2026, 09:00 Hrs [IST] UCB, a global biopharmaceutical company, ...
AT&T’s Plano headquarters campus will feature 2.3M SF of building space, a 280-foot tower, a daycare center, parking garages ...
Pathologists have been using the same routine method of detecting cancers for more than 100 years and now Queensland ...
Alpenglow Biosciences today announced Summit AI, its multimodal AI platform designed to analyze whole tissue volumes and convert complex imaging data into quantitative spatial readouts that remain ...
Techno-Science.net on MSN
⚕️ An AI against aggressive cancers
A research team from McGill University has developed an artificial intelligence tool capable of detecting the small groups of ...
Alloy Therapeutics, a leading biotechnology ecosystem company, today announced a strategic collaboration with the Institute for Protein Innovation (IPI), a nonprofit leader in protein engineering and ...
Researchers at the University of Toronto's Institute of Biomedical Engineering have developed a new method to mature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results